IPN goes super Sonic
Tuesday, 16 September, 2008
The proposed acquisition of the Independent Practitioner Network [ASX: IPN] by Sonic Healthcare [ASX: SHL] has been approved by IPN shareholders and will go ahead.
The companies received Federal Court approval to proceed with the merger yesterday.
IPN operates over 90 multidisciplinary medical practices in Australia. Sonic runs a number of pathology labs throughout the world, including Douglass Hanly Moir.
Under the arrangement, IPN shareholders will be given cash payments of $0.27 per share, just over the company's current trading price.
Sonic will take possession of all IPN shares on September 30.
A high-performance method for CRISPR off-target nomination
A new study provides evidence that can help gene editing developers prioritise biologically...
High doses of fertility drug linked to pregnancy risks
High doses of clomiphene citrate, accumulated over multiple fertility treatment cycles, could...
Bird flu vaccine to be rolled out to "priority" species
The Australian Government has announced the imminent rollout of a vaccine to protect some of...
